Grimaldi · Sleep 2019 · randomized sham-controlled trial · n=?

Strengthening sleep-autonomic interaction via acoustic enhancement of slow oscillations.

Cited 80 times in the scientific literature.

Level 2 - randomized trial

Randomized sham-controlled experimental trial in humans

PubMed 30753650 · doi:10.1093/sleep/zsz036 · record verified 2026-08-31

What was done

Healthy young adults received 50 ms acoustic stimuli phase-locked to slow waves delivered with regular pauses (~5 s ON / ~5 s OFF) via an adaptive algorithm during non-rapid eye-movement sleep. The intervention was evaluated against a sham condition to assess changes in slow-wave activity (SWA, 0.5–4 Hz), parasympathetic activity via heart rate variability (HRV) during slow-wave sleep, and evening-to-morning changes in HRV, plasma cortisol, and blood pressure.

What was found

Acoustic stimulation increased SWA during ON versus OFF intervals relative to sham. This SWA enhancement was associated with a reduction in evening-to-morning changes in plasma cortisol levels and sympathetic activity indices. In addition, SWA enhancement during ON intervals across sleep cycles 2 and 3 was accompanied by an increase in parasympathetic activity (high-frequency HRV). The abstract reports no numerical values, effect sizes, or p-values.

Why it matters

This study provides proof-of-concept that non-invasive acoustic slow-wave stimulation directly modulates autonomic nervous system activity and stress hormone dynamics during sleep, suggesting a potential pathway for sleep-based cardiovascular interventions.

Limits

The abstract does not report sample size, participant demographics beyond 'healthy young adults', or quantitative values (effect sizes, confidence intervals, p-values). Testing was restricted to acute overnight responses in healthy individuals, leaving long-term outcomes and clinical relevance unassessed.

Cited by